Cantitate/Preț
Produs

Monoclonal Antibody and Peptide–Targeted Radiotherapy of Cancer

Autor RM Reilly
en Limba Engleză Hardback – 27 aug 2010
Targeted radiotherapy relies on and exploits characteristics of cancer cells to attack tumors. Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer helps readers understand this hot pharmaceutical field with up-to-date developments. Expert discussion covers a range of diverse topics associated with this field, including the optimization of design of biomolecules and radiochemistry, cell and animal models for preclinical evaluation, discoveries from key clinical trials, radiation biology and dosimetry, and considerations in regulatory approval. With chapters authored by internationally renowned experts, this book delivers a wealth of information to push future discovery.
Citește tot Restrânge

Preț: 82775 lei

Preț vechi: 124520 lei
-34%

Puncte Express: 1242

Preț estimativ în valută:
15859 17178$ 135100£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780470243725
ISBN-10: 0470243724
Pagini: 648
Dimensiuni: 155 x 240 x 39 mm
Greutate: 1.1 kg
Editura: Wiley
Locul publicării:Hoboken, United States

Public țintă

Pharmaceutical scientists, pharmacologists, and medicinal– or biochemists working on cancer drugs, radiopharmaceutical scientists, radiochemists, health physicists, nuclear medicine professionals, students

Notă biografică

RAYMOND M. REILLY is a Professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto. He has more than twenty years of experience in the field of radiolabeled antibody and peptide targeting of cancer. Dr. Reilly has written over 180 publications in the field, including more than 100 scientific papers on radiopharmaceuticals for cancer imaging and targeted radiotherapy.

Cuprins